Olfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer’s Disease

Background: Early biomarkers of prodromal Alzheimer’s disease (AD) are critical both to initiate interventions and to choose participants for clinical trials. Odor threshold, odor identification and odor familiarity are impaired in AD. Methods: We investigated the relative abilities of standard scre...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paul Loyd Wheeler, Claire Murphy
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
MCI
Acceso en línea:https://doaj.org/article/11a5db0057634df992edc827a7340897
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:11a5db0057634df992edc827a7340897
record_format dspace
spelling oai:doaj.org-article:11a5db0057634df992edc827a73408972021-11-25T16:56:24ZOlfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer’s Disease10.3390/brainsci111113912076-3425https://doaj.org/article/11a5db0057634df992edc827a73408972021-10-01T00:00:00Zhttps://www.mdpi.com/2076-3425/11/11/1391https://doaj.org/toc/2076-3425Background: Early biomarkers of prodromal Alzheimer’s disease (AD) are critical both to initiate interventions and to choose participants for clinical trials. Odor threshold, odor identification and odor familiarity are impaired in AD. Methods: We investigated the relative abilities of standard screening (MMSE) and olfactory measures to predict transitions from cognitively normal (CN) to mild cognitive impairment (MCI), from CN to AD, and MCI to AD. The archival sample of 497, from the UCSD ADRC, included participants who were CN, MCI, AD and converters to MCI or AD. Apoe ε4 status, a genetic risk factor, was available for 256 participants, 132 were ε4 carriers. A receiver operating characteristic curve (ROC) curve plots the trade-off between sensitivity and specificity. Area under the ROC curve (AUC) was used to determine diagnostic accuracy. Results: Different measures were better predictors at specific stages of disease risk; e.g., odor familiarity, odor identification and the combination showed higher predictive value for converting from MCI to AD in ε4 carriers than the MMSE. Combining odor familiarity and odor identification produced an AUC of 1.0 in ε4 carriers, MMSE alone was 0.58. Conclusions: Olfactory biomarkers show real promise as non-invasive indicators of prodromal AD. The results support the value of combining olfactory measures in assessment of risk for conversion to MCI and to AD.Paul Loyd WheelerClaire MurphyMDPI AGarticleAlzheimer’s diseasebiomarkerMCIapolipoprotein Eodor thresholdodor identificationNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571ENBrain Sciences, Vol 11, Iss 1391, p 1391 (2021)
institution DOAJ
collection DOAJ
language EN
topic Alzheimer’s disease
biomarker
MCI
apolipoprotein E
odor threshold
odor identification
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
spellingShingle Alzheimer’s disease
biomarker
MCI
apolipoprotein E
odor threshold
odor identification
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Paul Loyd Wheeler
Claire Murphy
Olfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer’s Disease
description Background: Early biomarkers of prodromal Alzheimer’s disease (AD) are critical both to initiate interventions and to choose participants for clinical trials. Odor threshold, odor identification and odor familiarity are impaired in AD. Methods: We investigated the relative abilities of standard screening (MMSE) and olfactory measures to predict transitions from cognitively normal (CN) to mild cognitive impairment (MCI), from CN to AD, and MCI to AD. The archival sample of 497, from the UCSD ADRC, included participants who were CN, MCI, AD and converters to MCI or AD. Apoe ε4 status, a genetic risk factor, was available for 256 participants, 132 were ε4 carriers. A receiver operating characteristic curve (ROC) curve plots the trade-off between sensitivity and specificity. Area under the ROC curve (AUC) was used to determine diagnostic accuracy. Results: Different measures were better predictors at specific stages of disease risk; e.g., odor familiarity, odor identification and the combination showed higher predictive value for converting from MCI to AD in ε4 carriers than the MMSE. Combining odor familiarity and odor identification produced an AUC of 1.0 in ε4 carriers, MMSE alone was 0.58. Conclusions: Olfactory biomarkers show real promise as non-invasive indicators of prodromal AD. The results support the value of combining olfactory measures in assessment of risk for conversion to MCI and to AD.
format article
author Paul Loyd Wheeler
Claire Murphy
author_facet Paul Loyd Wheeler
Claire Murphy
author_sort Paul Loyd Wheeler
title Olfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer’s Disease
title_short Olfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer’s Disease
title_full Olfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer’s Disease
title_fullStr Olfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer’s Disease
title_full_unstemmed Olfactory Measures as Predictors of Conversion to Mild Cognitive Impairment and Alzheimer’s Disease
title_sort olfactory measures as predictors of conversion to mild cognitive impairment and alzheimer’s disease
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/11a5db0057634df992edc827a7340897
work_keys_str_mv AT paulloydwheeler olfactorymeasuresaspredictorsofconversiontomildcognitiveimpairmentandalzheimersdisease
AT clairemurphy olfactorymeasuresaspredictorsofconversiontomildcognitiveimpairmentandalzheimersdisease
_version_ 1718412819845611520